Source: FinanzNachrichten

Azafaros: Azafaros to Present at J.P. Morgan's 43rd Annual Healthcare Conference

Azafaros, a company focused on developing treatments for the unmet needs of patients with rare lysosomal storage disorders, today announced that it will present at J.P. Morgan's 43rd Annual Health...

Read full article »
Est. Annual Revenue
$25-100M
Est. Employees
25-100
Stefano Portolano's photo - CEO of Azafaros

CEO

Stefano Portolano

CEO Approval Rating

86/100

Read more